CD30 CAR T cells

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD30 CAR T cells, covering 2025-07-25 to 2025-07-25. Get the full timeline:

Most recent: Clinical Trial Update: CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30) [Phase 1]